Zheng Qu1, Shuohui Yang2, Feng Xing3, Rui Tong1, Chenyao Yang2, Rongfang Guo2, Jiling Huang2, Fang Lu2, Caixia Fu4, Xu Yan4, Stefanie Hectors5, Kelly Gillen5, Yi Wang5,6, Chenghai Liu3,7, Songhua Zhan2, Jianqi Li1. 1. Shanghai Key Laboratory of Magnetic Resonance, School of Physics and Electronic Science, East China Normal University, Shanghai, China. 2. Department of Radiology, Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine, Shanghai, China. 3. Department of Liver Diseases, Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine, Shanghai, China. 4. MR Collaboration NE Asia, Siemens Healthcare, Shanghai, China. 5. Department of Radiology, Weill Medical College of Cornell University, New York, NY, USA. 6. Department of Biomedical Engineering, Cornell University, Ithaca, NY, USA. 7. Shanghai Key Laboratory of Traditional Chinese Clinical Medicine, Shanghai, China.
Abstract
BACKGROUND: Noninvasive methods for the early diagnosis and staging of hepatic fibrosis are needed. The present study aimed to investigate the alteration of magnetic susceptibility in the liver of patients with various fibrosis stages and to evaluate the feasibility of using susceptibility to stage hepatic fibrosis. METHODS: A total of 30 consecutive patients with chronic liver diseases (CLDs) underwent magnetic resonance imaging (MRI) and liver biopsy evaluation of hepatic fibrosis, necroinflammatory activity, iron load, and steatosis. Quantitative susceptibility mapping (QSM), R2* and proton density fat fraction (PDFF) images were postprocessed from the same gradient-echo data for quantitative tissue characterization using region of interest (ROI) analysis. The differences for MRI measurements between cohorts of non-significant (Ishak-F <3) and significant fibrosis (Ishak-F ≥3) and the correlation of MRI measurements with fibrosis stages and necroinflammatory activity grades were tested. Receiver operating characteristic (ROC) analysis was also performed. RESULTS: There was a significant difference in liver susceptibility between the cohorts of significant and non-significant fibrosis (Z=-2.880, P=0.004). A moderate negative correlation between the stages of liver fibrosis and liver susceptibility was observed (r=-0.471, P=0.015). Liver magnetic susceptibility differentiated non-significant from significant hepatic fibrosis with an area under the receiver operating curve (AUC) of 0.836 (P=0.004). A highly sensitive diagnostic performance with an AUC of 0.933 was obtained using magnetic susceptibility and PDFF together (P<0.001). CONCLUSIONS: A noninvasive liver QSM-based evaluation promises an accurate assessment of significant fibrosis in patients with CLDs. 2021 Quantitative Imaging in Medicine and Surgery. All rights reserved.
BACKGROUND: Noninvasive methods for the early diagnosis and staging of hepatic fibrosis are needed. The present study aimed to investigate the alteration of magnetic susceptibility in the liver of patients with various fibrosis stages and to evaluate the feasibility of using susceptibility to stage hepatic fibrosis. METHODS: A total of 30 consecutive patients with chronic liver diseases (CLDs) underwent magnetic resonance imaging (MRI) and liver biopsy evaluation of hepatic fibrosis, necroinflammatory activity, iron load, and steatosis. Quantitative susceptibility mapping (QSM), R2* and proton density fat fraction (PDFF) images were postprocessed from the same gradient-echo data for quantitative tissue characterization using region of interest (ROI) analysis. The differences for MRI measurements between cohorts of non-significant (Ishak-F <3) and significant fibrosis (Ishak-F ≥3) and the correlation of MRI measurements with fibrosis stages and necroinflammatory activity grades were tested. Receiver operating characteristic (ROC) analysis was also performed. RESULTS: There was a significant difference in liver susceptibility between the cohorts of significant and non-significant fibrosis (Z=-2.880, P=0.004). A moderate negative correlation between the stages of liver fibrosis and liver susceptibility was observed (r=-0.471, P=0.015). Liver magnetic susceptibility differentiated non-significant from significant hepatic fibrosis with an area under the receiver operating curve (AUC) of 0.836 (P=0.004). A highly sensitive diagnostic performance with an AUC of 0.933 was obtained using magnetic susceptibility and PDFF together (P<0.001). CONCLUSIONS: A noninvasive liver QSM-based evaluation promises an accurate assessment of significant fibrosis in patients with CLDs. 2021 Quantitative Imaging in Medicine and Surgery. All rights reserved.
Authors: Tian Liu; Ildar Khalidov; Ludovic de Rochefort; Pascal Spincemaille; Jing Liu; A John Tsiouris; Yi Wang Journal: NMR Biomed Date: 2011-03-08 Impact factor: 4.044
Authors: Thomas Allkemper; Florian Sagmeister; Vito Cicinnati; Susanne Beckebaum; Hendrik Kooijman; Christian Kanthak; Christoph Stehling; Walter Heindel Journal: Radiology Date: 2013-12-13 Impact factor: 11.105
Authors: Alexey V Dimov; Tian Liu; Pascal Spincemaille; Jacob S Ecanow; Huan Tan; Robert R Edelman; Yi Wang Journal: Magn Reson Med Date: 2014-06-19 Impact factor: 4.668
Authors: Wai-Kay Seto; Rex W H Hui; Lung-Yi Mak; James Fung; Ka-Shing Cheung; Kevin S H Liu; Danny Ka-Ho Wong; Ching-Lung Lai; Man-Fung Yuen Journal: Clin Gastroenterol Hepatol Date: 2017-09-29 Impact factor: 11.382